» Articles » PMID: 25727379

Relaxation-compensated CEST-MRI of the Human Brain at 7T: Unbiased Insight into NOE and Amide Signal Changes in Human Glioblastoma

Overview
Journal Neuroimage
Specialty Radiology
Date 2015 Mar 3
PMID 25727379
Citations 91
Authors
Affiliations
Soon will be listed here.
Abstract

Endogenous chemical exchange saturation transfer (CEST) effects of protons resonating near to water protons are always diluted by competing effects such as direct water saturation and semi-solid magnetization transfer (MT). This leads to unwanted T2 and MT signal contributions that contaminate the observed CEST signal. Furthermore, all CEST effects appear to be scaled by the T1 relaxation time of the mediating water pool. As MT, T1 and T2 are also altered in tumor regions, a recently published correction algorithm yielding the apparent exchange-dependent relaxation AREX, is used to evaluate in vivo CEST effects. This study focuses on CEST effects of amides (3.5ppm) and Nuclear-Overhauser-mediated saturation transfer (NOE, -3.5ppm) that can be properly isolated at 7T. These were obtained in 10 glioblastoma patients, and this is the first comprehensive study where AREX is applied in human brain as well as in human glioblastoma. The correction of CEST effects alters the contrast significantly: after correction, the CEST effect of amides does not show significant contrast between contrast enhancing tumor regions and normal tissue, whereas NOE drops significantly in the tumor area. In addition, new features in the AREX contrasts are visible. This suggests that previous CEST approaches might not have shown pure CEST effects, but rather water relaxation shine-through effects. Our insights help to improve understanding of the CEST effect changes in tumors and correlations on a cellular and molecular level.

Citing Articles

The proton resonance enhancement for CEST imaging and shift exchange (PRECISE) family of RF pulse shapes for CEST MRI.

Mohanta Z, Stabinska J, Gilad A, Barker P, McMahon M Magn Reson Med. 2025; 93(5):1954-1968.

PMID: 39831452 PMC: 11893253. DOI: 10.1002/mrm.30410.


Clinical 7 Tesla magnetic resonance imaging: Impact and patient value in neurological disorders.

de Vries E, Hagbohm C, Ouellette R, Granberg T J Intern Med. 2025; 297(3):244-261.

PMID: 39775908 PMC: 11846079. DOI: 10.1111/joim.20059.


Improving quantification accuracy of a nuclear Overhauser enhancement signal at -1.6 ppm at 4.7 T using a machine learning approach.

Yin L, Viswanathan M, Kurmi Y, Zu Z Phys Med Biol. 2025; 70(2.

PMID: 39774035 PMC: 11740009. DOI: 10.1088/1361-6560/ada716.


Amide proton transfer weighted MRI measurements yield consistent and repeatable results in patients with gliomas: a prospective test-retest study.

Pfluger I, Rastogi A, Casagranda S, Papageorgakis C, Behnisch R, Liebig P Eur Radiol. 2024; .

PMID: 39694884 DOI: 10.1007/s00330-024-11197-2.


Multiparametric Chemical Exchange Saturation Transfer MRI Detects Metabolic Changes in Mild Cognitive Impairment Cases at 3.0 Tesla.

Zhu D, Fu X, Liu J, Liu X, Cheng L, Zhang X Neurochem Res. 2024; 50(1):51.

PMID: 39648256 DOI: 10.1007/s11064-024-04307-5.